nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—CYP2C19—Vismodegib—skin cancer	0.0915	0.135	CbGbCtD
Eletriptan—CYP2A6—Fluorouracil—skin cancer	0.0786	0.116	CbGbCtD
Eletriptan—CYP2C9—Vismodegib—skin cancer	0.0761	0.112	CbGbCtD
Eletriptan—ABCB1—Vismodegib—skin cancer	0.0739	0.109	CbGbCtD
Eletriptan—CYP3A4—Imiquimod—skin cancer	0.0638	0.0939	CbGbCtD
Eletriptan—CYP3A4—Temozolomide—skin cancer	0.0638	0.0939	CbGbCtD
Eletriptan—CYP2D6—Vemurafenib—skin cancer	0.055	0.0809	CbGbCtD
Eletriptan—CYP3A4—Vismodegib—skin cancer	0.0443	0.0651	CbGbCtD
Eletriptan—ABCB1—Dactinomycin—skin cancer	0.0388	0.0571	CbGbCtD
Eletriptan—CYP3A4—Vemurafenib—skin cancer	0.035	0.0514	CbGbCtD
Eletriptan—CYP2C9—Fluorouracil—skin cancer	0.027	0.0398	CbGbCtD
Eletriptan—ABCB1—Docetaxel—skin cancer	0.02	0.0295	CbGbCtD
Eletriptan—CYP3A4—Docetaxel—skin cancer	0.012	0.0177	CbGbCtD
Eletriptan—HTR1B—blood vessel—skin cancer	0.00139	0.0639	CbGeAlD
Eletriptan—HTR7—nerve—skin cancer	0.00137	0.0628	CbGeAlD
Eletriptan—HTR1D—blood vessel—skin cancer	0.00135	0.0619	CbGeAlD
Eletriptan—HTR7—endothelium—skin cancer	0.00116	0.0534	CbGeAlD
Eletriptan—HTR7—blood vessel—skin cancer	0.00107	0.0493	CbGeAlD
Eletriptan—HTR1F—head—skin cancer	0.00103	0.0471	CbGeAlD
Eletriptan—HTR1E—head—skin cancer	0.000888	0.0408	CbGeAlD
Eletriptan—PTGS1—endothelium—skin cancer	0.000804	0.0369	CbGeAlD
Eletriptan—HTR7—neck—skin cancer	0.000767	0.0353	CbGeAlD
Eletriptan—PTGS1—blood vessel—skin cancer	0.000741	0.0341	CbGeAlD
Eletriptan—HTR1D—connective tissue—skin cancer	0.00069	0.0317	CbGeAlD
Eletriptan—HTR2B—skin of body—skin cancer	0.00058	0.0266	CbGeAlD
Eletriptan—HTR7—connective tissue—skin cancer	0.00055	0.0253	CbGeAlD
Eletriptan—PTGS1—nipple—skin cancer	0.000536	0.0246	CbGeAlD
Eletriptan—HTR7—epithelium—skin cancer	0.000522	0.024	CbGeAlD
Eletriptan—HTR1B—female reproductive system—skin cancer	0.000503	0.0231	CbGeAlD
Eletriptan—HTR1D—female reproductive system—skin cancer	0.000487	0.0224	CbGeAlD
Eletriptan—HTR2B—female reproductive system—skin cancer	0.000453	0.0208	CbGeAlD
Eletriptan—ABCB1—blood vessel—skin cancer	0.000438	0.0201	CbGeAlD
Eletriptan—Pharyngitis—Temozolomide—skin cancer	0.000426	0.00147	CcSEcCtD
Eletriptan—Chills—Dactinomycin—skin cancer	0.000426	0.00147	CcSEcCtD
Eletriptan—Urinary tract disorder—Temozolomide—skin cancer	0.000424	0.00146	CcSEcCtD
Eletriptan—Oedema peripheral—Temozolomide—skin cancer	0.000423	0.00146	CcSEcCtD
Eletriptan—Pruritus—Vemurafenib—skin cancer	0.000423	0.00146	CcSEcCtD
Eletriptan—Urethral disorder—Temozolomide—skin cancer	0.000421	0.00145	CcSEcCtD
Eletriptan—HTR1B—head—skin cancer	0.00042	0.0193	CbGeAlD
Eletriptan—Alopecia—Dactinomycin—skin cancer	0.00042	0.00145	CcSEcCtD
Eletriptan—Feeling abnormal—Imiquimod—skin cancer	0.00042	0.00145	CcSEcCtD
Eletriptan—Gastrointestinal pain—Imiquimod—skin cancer	0.000417	0.00143	CcSEcCtD
Eletriptan—Epistaxis—Fluorouracil—skin cancer	0.000416	0.00143	CcSEcCtD
Eletriptan—Visual impairment—Temozolomide—skin cancer	0.000414	0.00143	CcSEcCtD
Eletriptan—Sinusitis—Fluorouracil—skin cancer	0.000414	0.00143	CcSEcCtD
Eletriptan—Ill-defined disorder—Bleomycin—skin cancer	0.000411	0.00142	CcSEcCtD
Eletriptan—Anaemia—Bleomycin—skin cancer	0.00041	0.00141	CcSEcCtD
Eletriptan—Diarrhoea—Vemurafenib—skin cancer	0.000409	0.00141	CcSEcCtD
Eletriptan—HTR1D—head—skin cancer	0.000407	0.0187	CbGeAlD
Eletriptan—Migraine—Docetaxel—skin cancer	0.000407	0.0014	CcSEcCtD
Eletriptan—Urticaria—Imiquimod—skin cancer	0.000405	0.00139	CcSEcCtD
Eletriptan—Body temperature increased—Imiquimod—skin cancer	0.000403	0.00139	CcSEcCtD
Eletriptan—Abdominal pain—Imiquimod—skin cancer	0.000403	0.00139	CcSEcCtD
Eletriptan—Tinnitus—Temozolomide—skin cancer	0.000401	0.00138	CcSEcCtD
Eletriptan—Malaise—Bleomycin—skin cancer	0.0004	0.00138	CcSEcCtD
Eletriptan—Flushing—Temozolomide—skin cancer	0.000399	0.00137	CcSEcCtD
Eletriptan—Leukopenia—Bleomycin—skin cancer	0.000397	0.00137	CcSEcCtD
Eletriptan—Rhinitis—Fluorouracil—skin cancer	0.000397	0.00137	CcSEcCtD
Eletriptan—Dizziness—Vemurafenib—skin cancer	0.000395	0.00136	CcSEcCtD
Eletriptan—Hypoaesthesia—Fluorouracil—skin cancer	0.000394	0.00136	CcSEcCtD
Eletriptan—Pharyngitis—Fluorouracil—skin cancer	0.000393	0.00135	CcSEcCtD
Eletriptan—Ataxia—Docetaxel—skin cancer	0.000388	0.00134	CcSEcCtD
Eletriptan—Immune system disorder—Temozolomide—skin cancer	0.000388	0.00134	CcSEcCtD
Eletriptan—HTR7—female reproductive system—skin cancer	0.000388	0.0178	CbGeAlD
Eletriptan—Cough—Bleomycin—skin cancer	0.000387	0.00133	CcSEcCtD
Eletriptan—Chills—Temozolomide—skin cancer	0.000386	0.00133	CcSEcCtD
Eletriptan—Ill-defined disorder—Dactinomycin—skin cancer	0.000384	0.00132	CcSEcCtD
Eletriptan—Anaemia—Dactinomycin—skin cancer	0.000382	0.00132	CcSEcCtD
Eletriptan—Liver function test abnormal—Docetaxel—skin cancer	0.000381	0.00131	CcSEcCtD
Eletriptan—PTGS1—connective tissue—skin cancer	0.00038	0.0175	CbGeAlD
Eletriptan—Vomiting—Vemurafenib—skin cancer	0.00038	0.00131	CcSEcCtD
Eletriptan—Alopecia—Temozolomide—skin cancer	0.00038	0.00131	CcSEcCtD
Eletriptan—Dry skin—Docetaxel—skin cancer	0.000379	0.0013	CcSEcCtD
Eletriptan—HTR2B—head—skin cancer	0.000378	0.0174	CbGeAlD
Eletriptan—Myalgia—Bleomycin—skin cancer	0.000377	0.0013	CcSEcCtD
Eletriptan—Abdominal pain upper—Docetaxel—skin cancer	0.000377	0.0013	CcSEcCtD
Eletriptan—Rash—Vemurafenib—skin cancer	0.000377	0.0013	CcSEcCtD
Eletriptan—Dermatitis—Vemurafenib—skin cancer	0.000376	0.0013	CcSEcCtD
Eletriptan—Hypersensitivity—Imiquimod—skin cancer	0.000375	0.00129	CcSEcCtD
Eletriptan—Headache—Vemurafenib—skin cancer	0.000374	0.00129	CcSEcCtD
Eletriptan—Discomfort—Bleomycin—skin cancer	0.000373	0.00128	CcSEcCtD
Eletriptan—Malaise—Dactinomycin—skin cancer	0.000373	0.00128	CcSEcCtD
Eletriptan—Cramp muscle—Docetaxel—skin cancer	0.000372	0.00128	CcSEcCtD
Eletriptan—Leukopenia—Dactinomycin—skin cancer	0.00037	0.00128	CcSEcCtD
Eletriptan—Dysgeusia—Temozolomide—skin cancer	0.000366	0.00126	CcSEcCtD
Eletriptan—Asthenia—Imiquimod—skin cancer	0.000365	0.00126	CcSEcCtD
Eletriptan—Confusional state—Bleomycin—skin cancer	0.000365	0.00126	CcSEcCtD
Eletriptan—Oedema—Bleomycin—skin cancer	0.000362	0.00125	CcSEcCtD
Eletriptan—Back pain—Temozolomide—skin cancer	0.000362	0.00125	CcSEcCtD
Eletriptan—PTGS1—epithelium—skin cancer	0.000361	0.0166	CbGeAlD
Eletriptan—Pruritus—Imiquimod—skin cancer	0.00036	0.00124	CcSEcCtD
Eletriptan—Dysphagia—Docetaxel—skin cancer	0.000357	0.00123	CcSEcCtD
Eletriptan—Nausea—Vemurafenib—skin cancer	0.000355	0.00122	CcSEcCtD
Eletriptan—Arrhythmia—Fluorouracil—skin cancer	0.000354	0.00122	CcSEcCtD
Eletriptan—Myalgia—Dactinomycin—skin cancer	0.000352	0.00121	CcSEcCtD
Eletriptan—Tremor—Temozolomide—skin cancer	0.00035	0.00121	CcSEcCtD
Eletriptan—Alopecia—Fluorouracil—skin cancer	0.00035	0.0012	CcSEcCtD
Eletriptan—Diarrhoea—Imiquimod—skin cancer	0.000349	0.0012	CcSEcCtD
Eletriptan—Discomfort—Dactinomycin—skin cancer	0.000348	0.0012	CcSEcCtD
Eletriptan—Angina pectoris—Docetaxel—skin cancer	0.000348	0.0012	CcSEcCtD
Eletriptan—Ill-defined disorder—Temozolomide—skin cancer	0.000347	0.0012	CcSEcCtD
Eletriptan—Anaemia—Temozolomide—skin cancer	0.000346	0.00119	CcSEcCtD
Eletriptan—Anorexia—Bleomycin—skin cancer	0.000345	0.00119	CcSEcCtD
Eletriptan—Agitation—Temozolomide—skin cancer	0.000344	0.00118	CcSEcCtD
Eletriptan—PTGS1—skin of body—skin cancer	0.000343	0.0158	CbGeAlD
Eletriptan—Angioedema—Temozolomide—skin cancer	0.000342	0.00118	CcSEcCtD
Eletriptan—HTR1A—head—skin cancer	0.000339	0.0156	CbGeAlD
Eletriptan—Hypotension—Bleomycin—skin cancer	0.000338	0.00116	CcSEcCtD
Eletriptan—Oedema—Dactinomycin—skin cancer	0.000337	0.00116	CcSEcCtD
Eletriptan—Malaise—Temozolomide—skin cancer	0.000337	0.00116	CcSEcCtD
Eletriptan—Dizziness—Imiquimod—skin cancer	0.000337	0.00116	CcSEcCtD
Eletriptan—Vertigo—Temozolomide—skin cancer	0.000336	0.00116	CcSEcCtD
Eletriptan—Leukopenia—Temozolomide—skin cancer	0.000335	0.00115	CcSEcCtD
Eletriptan—Palpitations—Temozolomide—skin cancer	0.000331	0.00114	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00033	0.00114	CcSEcCtD
Eletriptan—Cough—Temozolomide—skin cancer	0.000326	0.00112	CcSEcCtD
Eletriptan—Paraesthesia—Bleomycin—skin cancer	0.000325	0.00112	CcSEcCtD
Eletriptan—Weight increased—Docetaxel—skin cancer	0.000325	0.00112	CcSEcCtD
Eletriptan—Convulsion—Temozolomide—skin cancer	0.000324	0.00112	CcSEcCtD
Eletriptan—HTR7—head—skin cancer	0.000324	0.0149	CbGeAlD
Eletriptan—Vomiting—Imiquimod—skin cancer	0.000324	0.00112	CcSEcCtD
Eletriptan—Weight decreased—Docetaxel—skin cancer	0.000323	0.00111	CcSEcCtD
Eletriptan—Hypertension—Temozolomide—skin cancer	0.000323	0.00111	CcSEcCtD
Eletriptan—Dyspnoea—Bleomycin—skin cancer	0.000323	0.00111	CcSEcCtD
Eletriptan—Anorexia—Dactinomycin—skin cancer	0.000322	0.00111	CcSEcCtD
Eletriptan—Rash—Imiquimod—skin cancer	0.000321	0.00111	CcSEcCtD
Eletriptan—Dermatitis—Imiquimod—skin cancer	0.000321	0.00111	CcSEcCtD
Eletriptan—Headache—Imiquimod—skin cancer	0.000319	0.0011	CcSEcCtD
Eletriptan—Anaemia—Fluorouracil—skin cancer	0.000319	0.0011	CcSEcCtD
Eletriptan—Myalgia—Temozolomide—skin cancer	0.000318	0.0011	CcSEcCtD
Eletriptan—Arthralgia—Temozolomide—skin cancer	0.000318	0.0011	CcSEcCtD
Eletriptan—Anxiety—Temozolomide—skin cancer	0.000317	0.00109	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000316	0.00109	CcSEcCtD
Eletriptan—Discomfort—Temozolomide—skin cancer	0.000315	0.00108	CcSEcCtD
Eletriptan—Decreased appetite—Bleomycin—skin cancer	0.000315	0.00108	CcSEcCtD
Eletriptan—Acute coronary syndrome—Docetaxel—skin cancer	0.000314	0.00108	CcSEcCtD
Eletriptan—PTGS1—mammalian vulva—skin cancer	0.000313	0.0144	CbGeAlD
Eletriptan—Myocardial infarction—Docetaxel—skin cancer	0.000312	0.00107	CcSEcCtD
Eletriptan—Neuropathy peripheral—Docetaxel—skin cancer	0.000312	0.00107	CcSEcCtD
Eletriptan—Dry mouth—Temozolomide—skin cancer	0.000311	0.00107	CcSEcCtD
Eletriptan—Stomatitis—Docetaxel—skin cancer	0.00031	0.00107	CcSEcCtD
Eletriptan—Pain—Bleomycin—skin cancer	0.000309	0.00107	CcSEcCtD
Eletriptan—Conjunctivitis—Docetaxel—skin cancer	0.000309	0.00107	CcSEcCtD
Eletriptan—Leukopenia—Fluorouracil—skin cancer	0.000308	0.00106	CcSEcCtD
Eletriptan—Confusional state—Temozolomide—skin cancer	0.000308	0.00106	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000307	0.00106	CcSEcCtD
Eletriptan—Oedema—Temozolomide—skin cancer	0.000305	0.00105	CcSEcCtD
Eletriptan—Nausea—Imiquimod—skin cancer	0.000303	0.00104	CcSEcCtD
Eletriptan—Epistaxis—Docetaxel—skin cancer	0.0003	0.00103	CcSEcCtD
Eletriptan—Nervous system disorder—Temozolomide—skin cancer	0.000299	0.00103	CcSEcCtD
Eletriptan—Convulsion—Fluorouracil—skin cancer	0.000299	0.00103	CcSEcCtD
Eletriptan—Feeling abnormal—Bleomycin—skin cancer	0.000298	0.00103	CcSEcCtD
Eletriptan—Skin disorder—Temozolomide—skin cancer	0.000296	0.00102	CcSEcCtD
Eletriptan—Hyperhidrosis—Temozolomide—skin cancer	0.000295	0.00102	CcSEcCtD
Eletriptan—CYP2C9—female reproductive system—skin cancer	0.000294	0.0135	CbGeAlD
Eletriptan—Myalgia—Fluorouracil—skin cancer	0.000293	0.00101	CcSEcCtD
Eletriptan—Decreased appetite—Dactinomycin—skin cancer	0.000293	0.00101	CcSEcCtD
Eletriptan—Fatigue—Dactinomycin—skin cancer	0.000291	0.001	CcSEcCtD
Eletriptan—Anorexia—Temozolomide—skin cancer	0.000291	0.001	CcSEcCtD
Eletriptan—Discomfort—Fluorouracil—skin cancer	0.00029	0.000999	CcSEcCtD
Eletriptan—Pain—Dactinomycin—skin cancer	0.000289	0.000994	CcSEcCtD
Eletriptan—Urticaria—Bleomycin—skin cancer	0.000287	0.00099	CcSEcCtD
Eletriptan—Rhinitis—Docetaxel—skin cancer	0.000286	0.000987	CcSEcCtD
Eletriptan—Body temperature increased—Bleomycin—skin cancer	0.000286	0.000985	CcSEcCtD
Eletriptan—Hypoaesthesia—Docetaxel—skin cancer	0.000284	0.000979	CcSEcCtD
Eletriptan—Confusional state—Fluorouracil—skin cancer	0.000284	0.000977	CcSEcCtD
Eletriptan—Pharyngitis—Docetaxel—skin cancer	0.000284	0.000977	CcSEcCtD
Eletriptan—Urinary tract disorder—Docetaxel—skin cancer	0.000282	0.000972	CcSEcCtD
Eletriptan—Oedema peripheral—Docetaxel—skin cancer	0.000281	0.00097	CcSEcCtD
Eletriptan—Oedema—Fluorouracil—skin cancer	0.000281	0.000969	CcSEcCtD
Eletriptan—Urethral disorder—Docetaxel—skin cancer	0.00028	0.000965	CcSEcCtD
Eletriptan—Feeling abnormal—Dactinomycin—skin cancer	0.000278	0.000958	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000278	0.000958	CcSEcCtD
Eletriptan—Insomnia—Temozolomide—skin cancer	0.000276	0.000951	CcSEcCtD
Eletriptan—Gastrointestinal pain—Dactinomycin—skin cancer	0.000276	0.000951	CcSEcCtD
Eletriptan—Nervous system disorder—Fluorouracil—skin cancer	0.000276	0.00095	CcSEcCtD
Eletriptan—Visual impairment—Docetaxel—skin cancer	0.000275	0.000948	CcSEcCtD
Eletriptan—Tachycardia—Fluorouracil—skin cancer	0.000274	0.000946	CcSEcCtD
Eletriptan—Paraesthesia—Temozolomide—skin cancer	0.000274	0.000944	CcSEcCtD
Eletriptan—Dyspnoea—Temozolomide—skin cancer	0.000272	0.000937	CcSEcCtD
Eletriptan—Somnolence—Temozolomide—skin cancer	0.000271	0.000935	CcSEcCtD
Eletriptan—Dyspepsia—Temozolomide—skin cancer	0.000269	0.000926	CcSEcCtD
Eletriptan—Anorexia—Fluorouracil—skin cancer	0.000268	0.000923	CcSEcCtD
Eletriptan—PTGS1—female reproductive system—skin cancer	0.000268	0.0123	CbGeAlD
Eletriptan—Abdominal pain—Dactinomycin—skin cancer	0.000267	0.000919	CcSEcCtD
Eletriptan—Body temperature increased—Dactinomycin—skin cancer	0.000267	0.000919	CcSEcCtD
Eletriptan—Hypersensitivity—Bleomycin—skin cancer	0.000267	0.000918	CcSEcCtD
Eletriptan—Decreased appetite—Temozolomide—skin cancer	0.000265	0.000914	CcSEcCtD
Eletriptan—Flushing—Docetaxel—skin cancer	0.000265	0.000913	CcSEcCtD
Eletriptan—HTR2B—lymph node—skin cancer	0.000265	0.0122	CbGeAlD
Eletriptan—Gastrointestinal disorder—Temozolomide—skin cancer	0.000264	0.000908	CcSEcCtD
Eletriptan—Fatigue—Temozolomide—skin cancer	0.000263	0.000907	CcSEcCtD
Eletriptan—Hypotension—Fluorouracil—skin cancer	0.000263	0.000905	CcSEcCtD
Eletriptan—Constipation—Temozolomide—skin cancer	0.000261	0.000899	CcSEcCtD
Eletriptan—Pain—Temozolomide—skin cancer	0.000261	0.000899	CcSEcCtD
Eletriptan—Asthenia—Bleomycin—skin cancer	0.00026	0.000894	CcSEcCtD
Eletriptan—Immune system disorder—Docetaxel—skin cancer	0.000258	0.000889	CcSEcCtD
Eletriptan—Chills—Docetaxel—skin cancer	0.000256	0.000883	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000256	0.000883	CcSEcCtD
Eletriptan—Pruritus—Bleomycin—skin cancer	0.000256	0.000882	CcSEcCtD
Eletriptan—Arrhythmia—Docetaxel—skin cancer	0.000255	0.000879	CcSEcCtD
Eletriptan—Insomnia—Fluorouracil—skin cancer	0.000254	0.000876	CcSEcCtD
Eletriptan—Paraesthesia—Fluorouracil—skin cancer	0.000253	0.00087	CcSEcCtD
Eletriptan—Alopecia—Docetaxel—skin cancer	0.000252	0.00087	CcSEcCtD
Eletriptan—Feeling abnormal—Temozolomide—skin cancer	0.000252	0.000866	CcSEcCtD
Eletriptan—Dyspnoea—Fluorouracil—skin cancer	0.000251	0.000864	CcSEcCtD
Eletriptan—Somnolence—Fluorouracil—skin cancer	0.00025	0.000861	CcSEcCtD
Eletriptan—Gastrointestinal pain—Temozolomide—skin cancer	0.00025	0.00086	CcSEcCtD
Eletriptan—Hypersensitivity—Dactinomycin—skin cancer	0.000249	0.000857	CcSEcCtD
Eletriptan—Dyspepsia—Fluorouracil—skin cancer	0.000248	0.000853	CcSEcCtD
Eletriptan—Decreased appetite—Fluorouracil—skin cancer	0.000244	0.000842	CcSEcCtD
Eletriptan—Dysgeusia—Docetaxel—skin cancer	0.000244	0.000839	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000243	0.000836	CcSEcCtD
Eletriptan—Urticaria—Temozolomide—skin cancer	0.000242	0.000835	CcSEcCtD
Eletriptan—Asthenia—Dactinomycin—skin cancer	0.000242	0.000834	CcSEcCtD
Eletriptan—Body temperature increased—Temozolomide—skin cancer	0.000241	0.000831	CcSEcCtD
Eletriptan—Abdominal pain—Temozolomide—skin cancer	0.000241	0.000831	CcSEcCtD
Eletriptan—Back pain—Docetaxel—skin cancer	0.000241	0.000829	CcSEcCtD
Eletriptan—Pain—Fluorouracil—skin cancer	0.000241	0.000828	CcSEcCtD
Eletriptan—Muscle spasms—Docetaxel—skin cancer	0.000239	0.000824	CcSEcCtD
Eletriptan—Feeling abnormal—Fluorouracil—skin cancer	0.000232	0.000798	CcSEcCtD
Eletriptan—Diarrhoea—Dactinomycin—skin cancer	0.000231	0.000795	CcSEcCtD
Eletriptan—Vomiting—Bleomycin—skin cancer	0.00023	0.000793	CcSEcCtD
Eletriptan—Anaemia—Docetaxel—skin cancer	0.00023	0.000792	CcSEcCtD
Eletriptan—Rash—Bleomycin—skin cancer	0.000228	0.000786	CcSEcCtD
Eletriptan—Dermatitis—Bleomycin—skin cancer	0.000228	0.000785	CcSEcCtD
Eletriptan—Hypersensitivity—Temozolomide—skin cancer	0.000225	0.000775	CcSEcCtD
Eletriptan—PTGS1—head—skin cancer	0.000224	0.0103	CbGeAlD
Eletriptan—CYP3A4—female reproductive system—skin cancer	0.000224	0.0103	CbGeAlD
Eletriptan—Urticaria—Fluorouracil—skin cancer	0.000223	0.00077	CcSEcCtD
Eletriptan—Syncope—Docetaxel—skin cancer	0.000223	0.000768	CcSEcCtD
Eletriptan—Leukopenia—Docetaxel—skin cancer	0.000223	0.000767	CcSEcCtD
Eletriptan—Body temperature increased—Fluorouracil—skin cancer	0.000222	0.000766	CcSEcCtD
Eletriptan—CYP2D6—female reproductive system—skin cancer	0.00022	0.0101	CbGeAlD
Eletriptan—Palpitations—Docetaxel—skin cancer	0.00022	0.000757	CcSEcCtD
Eletriptan—Asthenia—Temozolomide—skin cancer	0.000219	0.000754	CcSEcCtD
Eletriptan—Loss of consciousness—Docetaxel—skin cancer	0.000219	0.000753	CcSEcCtD
Eletriptan—Cough—Docetaxel—skin cancer	0.000217	0.000748	CcSEcCtD
Eletriptan—Pruritus—Temozolomide—skin cancer	0.000216	0.000744	CcSEcCtD
Eletriptan—Convulsion—Docetaxel—skin cancer	0.000216	0.000742	CcSEcCtD
Eletriptan—Nausea—Bleomycin—skin cancer	0.000215	0.00074	CcSEcCtD
Eletriptan—Hypertension—Docetaxel—skin cancer	0.000215	0.00074	CcSEcCtD
Eletriptan—Vomiting—Dactinomycin—skin cancer	0.000215	0.000739	CcSEcCtD
Eletriptan—ABCB1—epithelium—skin cancer	0.000213	0.0098	CbGeAlD
Eletriptan—Rash—Dactinomycin—skin cancer	0.000213	0.000733	CcSEcCtD
Eletriptan—Arthralgia—Docetaxel—skin cancer	0.000212	0.000729	CcSEcCtD
Eletriptan—Myalgia—Docetaxel—skin cancer	0.000212	0.000729	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00021	0.000724	CcSEcCtD
Eletriptan—Diarrhoea—Temozolomide—skin cancer	0.000209	0.000719	CcSEcCtD
Eletriptan—Hypersensitivity—Fluorouracil—skin cancer	0.000207	0.000714	CcSEcCtD
Eletriptan—Dry mouth—Docetaxel—skin cancer	0.000207	0.000713	CcSEcCtD
Eletriptan—Confusional state—Docetaxel—skin cancer	0.000205	0.000705	CcSEcCtD
Eletriptan—Oedema—Docetaxel—skin cancer	0.000203	0.000699	CcSEcCtD
Eletriptan—Dizziness—Temozolomide—skin cancer	0.000202	0.000695	CcSEcCtD
Eletriptan—Nausea—Dactinomycin—skin cancer	0.0002	0.000691	CcSEcCtD
Eletriptan—Shock—Docetaxel—skin cancer	0.0002	0.000688	CcSEcCtD
Eletriptan—Nervous system disorder—Docetaxel—skin cancer	0.000199	0.000686	CcSEcCtD
Eletriptan—Pruritus—Fluorouracil—skin cancer	0.000199	0.000685	CcSEcCtD
Eletriptan—Tachycardia—Docetaxel—skin cancer	0.000198	0.000682	CcSEcCtD
Eletriptan—Skin disorder—Docetaxel—skin cancer	0.000197	0.000679	CcSEcCtD
Eletriptan—Vomiting—Temozolomide—skin cancer	0.000194	0.000669	CcSEcCtD
Eletriptan—Anorexia—Docetaxel—skin cancer	0.000193	0.000667	CcSEcCtD
Eletriptan—Rash—Temozolomide—skin cancer	0.000192	0.000663	CcSEcCtD
Eletriptan—Diarrhoea—Fluorouracil—skin cancer	0.000192	0.000663	CcSEcCtD
Eletriptan—Dermatitis—Temozolomide—skin cancer	0.000192	0.000662	CcSEcCtD
Eletriptan—Headache—Temozolomide—skin cancer	0.000191	0.000659	CcSEcCtD
Eletriptan—Hypotension—Docetaxel—skin cancer	0.00019	0.000653	CcSEcCtD
Eletriptan—Dizziness—Fluorouracil—skin cancer	0.000186	0.000641	CcSEcCtD
Eletriptan—ABCB1—mammalian vulva—skin cancer	0.000185	0.0085	CbGeAlD
Eletriptan—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000185	0.000637	CcSEcCtD
Eletriptan—CYP2D6—head—skin cancer	0.000184	0.00846	CbGeAlD
Eletriptan—Insomnia—Docetaxel—skin cancer	0.000184	0.000632	CcSEcCtD
Eletriptan—Paraesthesia—Docetaxel—skin cancer	0.000182	0.000628	CcSEcCtD
Eletriptan—Nausea—Temozolomide—skin cancer	0.000181	0.000625	CcSEcCtD
Eletriptan—Dyspnoea—Docetaxel—skin cancer	0.000181	0.000623	CcSEcCtD
Eletriptan—Somnolence—Docetaxel—skin cancer	0.00018	0.000622	CcSEcCtD
Eletriptan—Vomiting—Fluorouracil—skin cancer	0.000179	0.000616	CcSEcCtD
Eletriptan—Dyspepsia—Docetaxel—skin cancer	0.000179	0.000616	CcSEcCtD
Eletriptan—Rash—Fluorouracil—skin cancer	0.000177	0.000611	CcSEcCtD
Eletriptan—Dermatitis—Fluorouracil—skin cancer	0.000177	0.00061	CcSEcCtD
Eletriptan—Decreased appetite—Docetaxel—skin cancer	0.000176	0.000608	CcSEcCtD
Eletriptan—Headache—Fluorouracil—skin cancer	0.000176	0.000607	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Docetaxel—skin cancer	0.000175	0.000604	CcSEcCtD
Eletriptan—Fatigue—Docetaxel—skin cancer	0.000175	0.000603	CcSEcCtD
Eletriptan—Pain—Docetaxel—skin cancer	0.000174	0.000598	CcSEcCtD
Eletriptan—Constipation—Docetaxel—skin cancer	0.000174	0.000598	CcSEcCtD
Eletriptan—Feeling abnormal—Docetaxel—skin cancer	0.000167	0.000576	CcSEcCtD
Eletriptan—Nausea—Fluorouracil—skin cancer	0.000167	0.000575	CcSEcCtD
Eletriptan—Gastrointestinal pain—Docetaxel—skin cancer	0.000166	0.000572	CcSEcCtD
Eletriptan—ABCB1—lymphoid tissue—skin cancer	0.000164	0.00755	CbGeAlD
Eletriptan—Body temperature increased—Docetaxel—skin cancer	0.00016	0.000553	CcSEcCtD
Eletriptan—Abdominal pain—Docetaxel—skin cancer	0.00016	0.000553	CcSEcCtD
Eletriptan—ABCB1—female reproductive system—skin cancer	0.000158	0.00728	CbGeAlD
Eletriptan—PTGS1—lymph node—skin cancer	0.000157	0.00721	CbGeAlD
Eletriptan—Hypersensitivity—Docetaxel—skin cancer	0.00015	0.000515	CcSEcCtD
Eletriptan—Asthenia—Docetaxel—skin cancer	0.000146	0.000502	CcSEcCtD
Eletriptan—Pruritus—Docetaxel—skin cancer	0.000144	0.000495	CcSEcCtD
Eletriptan—Diarrhoea—Docetaxel—skin cancer	0.000139	0.000478	CcSEcCtD
Eletriptan—Dizziness—Docetaxel—skin cancer	0.000134	0.000462	CcSEcCtD
Eletriptan—ABCB1—head—skin cancer	0.000132	0.00608	CbGeAlD
Eletriptan—Vomiting—Docetaxel—skin cancer	0.000129	0.000445	CcSEcCtD
Eletriptan—Rash—Docetaxel—skin cancer	0.000128	0.000441	CcSEcCtD
Eletriptan—Dermatitis—Docetaxel—skin cancer	0.000128	0.00044	CcSEcCtD
Eletriptan—Headache—Docetaxel—skin cancer	0.000127	0.000438	CcSEcCtD
Eletriptan—Nausea—Docetaxel—skin cancer	0.000121	0.000415	CcSEcCtD
Eletriptan—ABCB1—lymph node—skin cancer	9.27e-05	0.00426	CbGeAlD
Eletriptan—HTR1F—Signaling by GPCR—PTCH1—skin cancer	2.13e-05	0.00268	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—SHH—skin cancer	2.11e-05	0.00267	CbGpPWpGaD
Eletriptan—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	2.1e-05	0.00265	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	2.09e-05	0.00264	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—SHH—skin cancer	2.08e-05	0.00263	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—PTCH2—skin cancer	2.08e-05	0.00262	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—PTGER4—skin cancer	2.07e-05	0.00261	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—MC1R—skin cancer	2.04e-05	0.00257	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—MC1R—skin cancer	2.03e-05	0.00255	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—MC1R—skin cancer	2.01e-05	0.00254	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—PTCH1—skin cancer	2e-05	0.00253	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—SMO—skin cancer	2e-05	0.00253	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—PTCH1—skin cancer	1.98e-05	0.00249	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—SMO—skin cancer	1.98e-05	0.00249	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—MC1R—skin cancer	1.97e-05	0.00248	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—PTGER4—skin cancer	1.95e-05	0.00246	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—GLI2—skin cancer	1.95e-05	0.00246	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—PTGER4—skin cancer	1.92e-05	0.00243	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—MC1R—skin cancer	1.86e-05	0.00234	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—MC1R—skin cancer	1.85e-05	0.00233	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—GLI2—skin cancer	1.84e-05	0.00232	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—GLI1—skin cancer	1.83e-05	0.00231	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—MC1R—skin cancer	1.75e-05	0.00221	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—SUFU—skin cancer	1.74e-05	0.00219	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—GLI1—skin cancer	1.73e-05	0.00218	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.72e-05	0.00217	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PTCH2—skin cancer	1.65e-05	0.00209	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—MC1R—skin cancer	1.65e-05	0.00208	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PTCH2—skin cancer	1.64e-05	0.00207	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—SUFU—skin cancer	1.64e-05	0.00207	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PTCH2—skin cancer	1.61e-05	0.00203	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.57e-05	0.00198	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.52e-05	0.00191	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PTCH2—skin cancer	1.51e-05	0.00191	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—MC1R—skin cancer	1.5e-05	0.00189	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—PTGER4—skin cancer	1.47e-05	0.00185	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—PTGER4—skin cancer	1.46e-05	0.00184	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—SHH—skin cancer	1.44e-05	0.00182	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—SHH—skin cancer	1.43e-05	0.00181	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—PTGER4—skin cancer	1.43e-05	0.0018	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—SHH—skin cancer	1.4e-05	0.00177	CbGpPWpGaD
Eletriptan—PTGS1—Selenium Micronutrient Network—IL6—skin cancer	1.38e-05	0.00175	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—SMO—skin cancer	1.37e-05	0.00173	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—PTCH1—skin cancer	1.37e-05	0.00173	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—PTCH1—skin cancer	1.36e-05	0.00171	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—SMO—skin cancer	1.36e-05	0.00171	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—PTGER4—skin cancer	1.34e-05	0.00169	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—PTGER4—skin cancer	1.33e-05	0.00168	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PLIN2—skin cancer	1.33e-05	0.00168	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—SMO—skin cancer	1.33e-05	0.00168	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—PTCH1—skin cancer	1.33e-05	0.00168	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—SHH—skin cancer	1.32e-05	0.00167	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—PTGER4—skin cancer	1.32e-05	0.00167	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—SHH—skin cancer	1.32e-05	0.00166	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—RASA1—skin cancer	1.32e-05	0.00166	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—PTGER4—skin cancer	1.3e-05	0.00163	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PLIN2—skin cancer	1.26e-05	0.00159	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—PTCH1—skin cancer	1.26e-05	0.00158	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—SMO—skin cancer	1.26e-05	0.00158	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—GLI2—skin cancer	1.25e-05	0.00158	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—PTCH1—skin cancer	1.25e-05	0.00158	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—SMO—skin cancer	1.25e-05	0.00158	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—SHH—skin cancer	1.25e-05	0.00158	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—GLI2—skin cancer	1.25e-05	0.00157	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—RASA1—skin cancer	1.24e-05	0.00157	CbGpPWpGaD
Eletriptan—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—skin cancer	1.23e-05	0.00156	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PTCH2—skin cancer	1.23e-05	0.00155	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—PTGER4—skin cancer	1.22e-05	0.00154	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—GLI2—skin cancer	1.22e-05	0.00154	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—PTGER4—skin cancer	1.22e-05	0.00153	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—MC1R—skin cancer	1.2e-05	0.00151	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—MC1R—skin cancer	1.19e-05	0.0015	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—PTCH1—skin cancer	1.18e-05	0.00149	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—SMO—skin cancer	1.18e-05	0.00149	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—GLI1—skin cancer	1.18e-05	0.00149	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—GLI1—skin cancer	1.17e-05	0.00148	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—MC1R—skin cancer	1.16e-05	0.00147	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—PTGER4—skin cancer	1.15e-05	0.00145	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—GLI1—skin cancer	1.15e-05	0.00145	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—GLI2—skin cancer	1.15e-05	0.00145	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SUFU—skin cancer	1.12e-05	0.00141	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SUFU—skin cancer	1.11e-05	0.0014	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—MC1R—skin cancer	1.09e-05	0.00138	CbGpPWpGaD
Eletriptan—HTR7—Circadian rythm related genes—TP53—skin cancer	1.09e-05	0.00138	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SUFU—skin cancer	1.09e-05	0.00137	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—PTGER4—skin cancer	1.09e-05	0.00137	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—FOXO4—skin cancer	1.08e-05	0.00136	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—GLI1—skin cancer	1.08e-05	0.00136	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	1.08e-05	0.00136	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—CSPG4—skin cancer	1.07e-05	0.00135	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—SHH—skin cancer	1.07e-05	0.00135	CbGpPWpGaD
Eletriptan—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—skin cancer	1.06e-05	0.00134	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SUFU—skin cancer	1.02e-05	0.00129	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—FOXO4—skin cancer	1.02e-05	0.00128	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—CSPG4—skin cancer	1.02e-05	0.00128	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—PTCH1—skin cancer	1.01e-05	0.00128	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—SMO—skin cancer	1.01e-05	0.00128	CbGpPWpGaD
Eletriptan—HTR7—Circadian rythm related genes—IL6—skin cancer	9.99e-06	0.00126	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—PTGER4—skin cancer	9.87e-06	0.00124	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—GLI2—skin cancer	9.29e-06	0.00117	CbGpPWpGaD
Eletriptan—HTR1A—SIDS Susceptibility Pathways—IL6—skin cancer	9.06e-06	0.00114	CbGpPWpGaD
Eletriptan—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—skin cancer	9.03e-06	0.00114	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—MC1R—skin cancer	8.87e-06	0.00112	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—GLI1—skin cancer	8.74e-06	0.0011	CbGpPWpGaD
Eletriptan—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—skin cancer	8.65e-06	0.00109	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SHH—skin cancer	8.53e-06	0.00108	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—RASA1—skin cancer	8.47e-06	0.00107	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SHH—skin cancer	8.47e-06	0.00107	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—RASA1—skin cancer	8.42e-06	0.00106	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SHH—skin cancer	8.29e-06	0.00105	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SUFU—skin cancer	8.28e-06	0.00104	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—RASA1—skin cancer	8.24e-06	0.00104	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PTCH1—skin cancer	8.08e-06	0.00102	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SMO—skin cancer	8.08e-06	0.00102	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SMO—skin cancer	8.03e-06	0.00101	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PTCH1—skin cancer	8.03e-06	0.00101	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PTGER4—skin cancer	7.87e-06	0.000992	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PTCH1—skin cancer	7.86e-06	0.000992	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SMO—skin cancer	7.86e-06	0.000992	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PTGER4—skin cancer	7.82e-06	0.000986	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SHH—skin cancer	7.79e-06	0.000983	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—RASA1—skin cancer	7.74e-06	0.000976	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	7.69e-06	0.00097	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PLIN2—skin cancer	7.68e-06	0.000968	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PTGER4—skin cancer	7.65e-06	0.000965	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PLIN2—skin cancer	7.49e-06	0.000945	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PTCH1—skin cancer	7.39e-06	0.000931	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SMO—skin cancer	7.39e-06	0.000931	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—ENO2—skin cancer	7.3e-06	0.00092	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TERT—skin cancer	7.21e-06	0.000909	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PTGER4—skin cancer	7.19e-06	0.000907	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PLIN2—skin cancer	7.06e-06	0.000891	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PLIN2—skin cancer	7e-06	0.000883	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—FOXO4—skin cancer	6.95e-06	0.000877	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—FOXO4—skin cancer	6.9e-06	0.000871	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—ENO2—skin cancer	6.9e-06	0.00087	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TERT—skin cancer	6.8e-06	0.000858	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—FOXO4—skin cancer	6.76e-06	0.000853	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—FOXO4—skin cancer	6.35e-06	0.000801	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SHH—skin cancer	6.32e-06	0.000797	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—RASA1—skin cancer	6.28e-06	0.000792	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CSPG4—skin cancer	6.19e-06	0.000781	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—NRAS—skin cancer	6.08e-06	0.000766	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CSPG4—skin cancer	6.04e-06	0.000762	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SMO—skin cancer	5.99e-06	0.000755	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PTCH1—skin cancer	5.99e-06	0.000755	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PTGER4—skin cancer	5.83e-06	0.000735	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—NRAS—skin cancer	5.73e-06	0.000723	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—BRAF—skin cancer	5.71e-06	0.00072	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.71e-06	0.00072	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CSPG4—skin cancer	5.69e-06	0.000718	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CSPG4—skin cancer	5.64e-06	0.000712	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—BRAF—skin cancer	5.39e-06	0.000679	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—KRAS—skin cancer	5.23e-06	0.00066	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—FOXO4—skin cancer	5.15e-06	0.00065	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	5.15e-06	0.00065	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—KRAS—skin cancer	4.93e-06	0.000622	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TERT—skin cancer	4.64e-06	0.000585	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PLIN2—skin cancer	4.62e-06	0.000582	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TERT—skin cancer	4.61e-06	0.000582	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	4.58e-06	0.000577	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TERT—skin cancer	4.52e-06	0.000569	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—HRAS—skin cancer	4.44e-06	0.000561	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—IL6—skin cancer	4.25e-06	0.000537	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TERT—skin cancer	4.24e-06	0.000535	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—ERCC2—skin cancer	4.24e-06	0.000535	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ENO2—skin cancer	4.21e-06	0.000531	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—HRAS—skin cancer	4.19e-06	0.000529	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ENO2—skin cancer	4.11e-06	0.000518	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—IL6—skin cancer	4.01e-06	0.000506	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—ERCC2—skin cancer	4.01e-06	0.000505	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—NRAS—skin cancer	3.91e-06	0.000493	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—NRAS—skin cancer	3.89e-06	0.00049	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ENO2—skin cancer	3.87e-06	0.000488	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ENO2—skin cancer	3.84e-06	0.000484	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—NRAS—skin cancer	3.8e-06	0.00048	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CSPG4—skin cancer	3.72e-06	0.000469	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—BRAF—skin cancer	3.68e-06	0.000464	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—BRAF—skin cancer	3.65e-06	0.000461	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—NRAS—skin cancer	3.59e-06	0.000453	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—BRAF—skin cancer	3.58e-06	0.000451	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—NRAS—skin cancer	3.57e-06	0.000451	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TERT—skin cancer	3.44e-06	0.000434	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—NRAS—skin cancer	3.39e-06	0.000427	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—KRAS—skin cancer	3.37e-06	0.000425	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—BRAF—skin cancer	3.36e-06	0.000424	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—KRAS—skin cancer	3.34e-06	0.000422	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.29e-06	0.000415	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—KRAS—skin cancer	3.27e-06	0.000413	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—KRAS—skin cancer	3.09e-06	0.00039	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—KRAS—skin cancer	3.08e-06	0.000388	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3e-06	0.000378	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—KRAS—skin cancer	2.91e-06	0.000368	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—NRAS—skin cancer	2.9e-06	0.000366	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—HRAS—skin cancer	2.86e-06	0.000361	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—HRAS—skin cancer	2.84e-06	0.000358	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—HRAS—skin cancer	2.78e-06	0.000351	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TP53—skin cancer	2.75e-06	0.000346	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—IL6—skin cancer	2.74e-06	0.000345	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—BRAF—skin cancer	2.72e-06	0.000344	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—IL6—skin cancer	2.72e-06	0.000343	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—IL6—skin cancer	2.66e-06	0.000336	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—HRAS—skin cancer	2.63e-06	0.000331	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—HRAS—skin cancer	2.61e-06	0.00033	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TP53—skin cancer	2.59e-06	0.000327	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—PTGS2—skin cancer	2.54e-06	0.000321	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ENO2—skin cancer	2.53e-06	0.000319	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—IL6—skin cancer	2.51e-06	0.000317	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—IL6—skin cancer	2.5e-06	0.000316	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—KRAS—skin cancer	2.49e-06	0.000315	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—HRAS—skin cancer	2.48e-06	0.000312	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ERCC2—skin cancer	2.44e-06	0.000308	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—PTGS2—skin cancer	2.4e-06	0.000303	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ERCC2—skin cancer	2.39e-06	0.000301	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—IL6—skin cancer	2.37e-06	0.000299	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—NRAS—skin cancer	2.31e-06	0.000291	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—NRAS—skin cancer	2.3e-06	0.000289	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ERCC2—skin cancer	2.25e-06	0.000283	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—NRAS—skin cancer	2.25e-06	0.000283	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ERCC2—skin cancer	2.23e-06	0.000281	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—HRAS—skin cancer	2.12e-06	0.000267	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—NRAS—skin cancer	2.11e-06	0.000266	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—IL6—skin cancer	2.03e-06	0.000256	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—KRAS—skin cancer	1.99e-06	0.000251	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—KRAS—skin cancer	1.98e-06	0.000249	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—KRAS—skin cancer	1.93e-06	0.000244	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—KRAS—skin cancer	1.82e-06	0.000229	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TP53—skin cancer	1.77e-06	0.000223	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TP53—skin cancer	1.76e-06	0.000221	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TP53—skin cancer	1.72e-06	0.000217	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—NRAS—skin cancer	1.71e-06	0.000216	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—HRAS—skin cancer	1.69e-06	0.000213	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—HRAS—skin cancer	1.68e-06	0.000212	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—HRAS—skin cancer	1.64e-06	0.000207	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—IL6—skin cancer	1.62e-06	0.000204	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TP53—skin cancer	1.61e-06	0.000204	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—IL6—skin cancer	1.61e-06	0.000203	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—IL6—skin cancer	1.57e-06	0.000198	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—HRAS—skin cancer	1.54e-06	0.000195	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—IL6—skin cancer	1.48e-06	0.000186	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—KRAS—skin cancer	1.47e-06	0.000186	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ERCC2—skin cancer	1.47e-06	0.000185	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—PTGS2—skin cancer	1.47e-06	0.000185	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—PTGS2—skin cancer	1.43e-06	0.00018	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—PTGS2—skin cancer	1.35e-06	0.00017	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—PTGS2—skin cancer	1.34e-06	0.000169	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TP53—skin cancer	1.31e-06	0.000165	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—HRAS—skin cancer	1.25e-06	0.000158	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—IL6—skin cancer	1.2e-06	0.000151	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—PTGS2—skin cancer	8.81e-07	0.000111	CbGpPWpGaD
